Physcians are balking at attending meetings—a result of one of many regulatory challenges industry meetings planners are besieged with on a weekly basis. A new report reveals what pharmaceutical companies are doing about it.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial